33,530 results
- US 2026/0324288 A1Published 15 Oct 2026Organic electroluminescent materials and devices
Universal Display Corporation
- US 2026/0324287 A1Published 15 Oct 2026Organic electroluminescent materials and devices
Universal Display Corporation
- US 2026/0324286 A1Published 15 Oct 2026
- US 2026/0324281 A1Published 15 Oct 2026Heterocyclic compound and organic light-emitting device comprising same
Lt Materials Co., Ltd.
- US 2026/0324277 A1Published 15 Oct 2026
- US 2026/0324276 A1Published 15 Oct 2026Organic electroluminescent materials and devices
Universal Display Corporation
- US 2026/0324190 A1Published 15 Oct 2026
- US 2026/0324187 A1Published 15 Oct 2026Organic electrluminescent material and device thereof
Beijing Summer Sprout Technology Co., Ltd.
- US 2026/0317367 A1Published 15 Oct 2026Salts including crystalline salts of 25-hydroxy-cholest-5-en-3-sulfate and methods for preparing same
Andrew R. Miksztal, WeiQi Lin +1inventors
- US 2026/0317355 A1Published 15 Oct 2026
- US 2026/0317349 A1Published 15 Oct 2026Macrocyclic chelating agent capable of site-specific modification, radionuclide probe, and use thereof
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- US 2026/0317344 A1Published 15 Oct 2026Egfr inhibitors for treating disease
Blossomhill Therapeutics, Inc.
- US 2026/0317337 A1Published 15 Oct 2026Heterocyclic compounds for imaging aggregated alpha synuclein in the synucleinopathies
The Trustees of the University of Pennsylvania
- US 2026/0317332 A1Published 15 Oct 2026Bicyclic heterocycle compounds for the treatment of cancer
Hoffmann-La Roche Inc.
- US 2026/0317330 A1Published 15 Oct 2026Salts of r-ketorolac
UNM Rainforest Innovations
- US 2026/0317322 A1Published 15 Oct 2026Tetrahydrocarbazole derivative, pharmaceutical composition and use thereof
Nain Biotech (Hangzhou) Co., Ltd.
- US 2026/0317319 A1Published 15 Oct 2026Novel ergolines and methods of treating mood disorders
Gilgamesh Pharma Inc.
- US 2026/0317317 A1Published 15 Oct 2026
- US 2026/0317313 A1Published 15 Oct 2026DNA Polymerase Theta Inhibitors Containing Non-Saturated 5-Membered Heterocyclic Rings and Use Thereof
Thomas Jefferson University
- US 2026/0317307 A1Published 15 Oct 2026Process for the Preparation of Deucravacitinib, and Crystalline Forms Thereof
Venkata Raghavendra Charyulu Palle, Pratik R. Patel +1inventors
- US 2026/0317296 A1Published 15 Oct 2026Heterocyclic compounds for imaging aggregated tau in tauopathies
University of Pittsburgh—Of the Commonwealth System of Higher Education
- US 2026/0317295 A1Published 15 Oct 2026Nav1.8 inhibitors, preparation method therefor and use thereof
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- US 2026/0317286 A1Published 15 Oct 2026Small molecule inhibitors of glutamine transporter asct2 and methods of use thereof
Henry Charles MANNING, Cong-Dat PHAM +1inventors
- US 2026/0317285 A1Published 15 Oct 2026Methods and compositions for gamma-glutamyl cycle modulation
Cancer Research Technologies Limited
- US 2026/0317267 A1Published 15 Oct 2026Systems and methods for generation of hyperpolarized materials
Nvision Imaging Technologies GmbH